| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/07/2026 | ±4.9% | -3.1% | over-priced |
| 05/06/2026 | ±4.8% | -2.0% | over-priced |
| 02/19/2026 | ±4.5% | -2.4% | over-priced |
| 10/30/2025 | ±19.5% | -7.7% | over-priced |
| 07/24/2025 | ±6.6% | -2.0% | over-priced |
| 04/25/2025 | ±7.8% | +0.4% | over-priced |
| 02/20/2025 | ±1.6% | -0.8% | over-priced |
| 10/23/2024 | ±2.4% | +1.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.17 | $5.3B | $627M |
| Q1 FY2026 | $1.07 | $5.0B | $571M |
| Q4 FY2025 | — | $5.3B | $811M |
| Q3 FY2025 | $1.46 | $5.3B | $792M |
FISV (FISV) reports in 13 days, with the next report estimated for 11/09/2026. Across the last 8 reports, options priced an average ±6.5% earnings move while the stock actually moved 2.5% on average — the market has systematically over-priced FISV's earnings risk. Fundamentals into the print: EPS down 37.1% year-over-year, revenue down 4.1%. QuantLogix's live 5-factor engine currently reads FISV as a neutral at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →